Chris Higgs

1.4k total citations
35 papers, 716 citations indexed

About

Chris Higgs is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Chris Higgs has authored 35 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 12 papers in Virology and 11 papers in Epidemiology. Recurrent topics in Chris Higgs's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (10 papers). Chris Higgs is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (10 papers). Chris Higgs collaborates with scholars based in United Kingdom, New Zealand and United States. Chris Higgs's co-authors include Marta Boffito, Graeme Moyle, David Back, Mark Nelson, Akil Jackson, John C. Shelley, Edward Lyman, Gregory A. Voth, Ramy Farid and Byungchan Kim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neuroscience and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Chris Higgs

32 papers receiving 698 citations

Peers

Chris Higgs
Joan Albert Arnáiz Spain
Maria José Míguez‐Burbano United States
Birgit Kvinesdal Denmark
Haijiang Lin China
Daniel Pearce United States
Isabelle Kousignian France
Anthony T. Podany United States
Miranda Murray United Kingdom
Carlin Rafie United States
William P. Howlett Tanzania
Joan Albert Arnáiz Spain
Chris Higgs
Citations per year, relative to Chris Higgs Chris Higgs (= 1×) peers Joan Albert Arnáiz

Countries citing papers authored by Chris Higgs

Since Specialization
Citations

This map shows the geographic impact of Chris Higgs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Higgs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Higgs more than expected).

Fields of papers citing papers by Chris Higgs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Higgs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Higgs. The network helps show where Chris Higgs may publish in the future.

Co-authorship network of co-authors of Chris Higgs

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Higgs. A scholar is included among the top collaborators of Chris Higgs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Higgs. Chris Higgs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stokes, Tim, Amanda Wilkinson, Prasath Jayakaran, et al.. (2022). Implementation of the Diabetes Community Exercise and Education Programme (DCEP) for the management of type 2 diabetes: qualitative process evaluation. BMJ Open. 12(5). e059853–e059853. 2 indexed citations
2.
Wilkinson, Amanda, Chris Higgs, Tim Stokes, Jack Dummer, & Leigh Hale. (2022). How to Best Develop and Deliver Generic Long-Term Condition Rehabilitation Programmes in Rural Settings: An Integrative Review. SHILAP Revista de lepidopterología. 3. 904007–904007. 1 indexed citations
3.
Hale, Leigh, et al.. (2022). It Is “All About Relationships” in Lifestyle Programmes for Adults Living With Type Two Diabetes Underpinned by a Person/Whānau-Centred Care Approach. SHILAP Revista de lepidopterología. 3. 829542–829542. 3 indexed citations
4.
Hale, Leigh, Chris Higgs, Andrew Gray, et al.. (2022). The diabetes community exercise programme plus usual care versus usual care in patients with type 2 diabetes: A randomised, two-arm, parallel, open-label trial. EClinicalMedicine. 46. 101361–101361. 6 indexed citations
5.
Hale, Leigh, Tim Stokes, Ramakrishnan Mani, et al.. (2019). Protocol for a randomised controlled trial to evaluate the effectiveness of the diabetes community exercise and education programme (DCEP) for long-term management of diabetes. BMJ Open. 9(2). e025578–e025578. 6 indexed citations
6.
7.
Amara, Alieu, Nicole Pagani, Laura Else, et al.. (2017). Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge. Journal of Antimicrobial Chemotherapy. 72(7). 2035–2041. 6 indexed citations
8.
Rai, Tanvi, et al.. (2017). P4.18 Not so normalised – patient perspectives on hiv diagnosis and treatment decisions: results from a large qualitative study in london. HighWire Press Open Archive. A198.2–A198. 1 indexed citations
9.
Higgs, Chris, Margot Skinner, & Leigh Hale. (2016). Outcomes of a community-based lifestyle programme for adults with diabetes or pre-diabetes. Journal of Primary Health Care. 8(2). 130–139. 18 indexed citations
10.
Dickinson, Laura, H. Manisha Yapa, Akil Jackson, et al.. (2015). Plasma Tenofovir, Emtricitabine, and Rilpivirine and Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate Pharmacokinetics following Drug Intake Cessation. Antimicrobial Agents and Chemotherapy. 59(10). 6080–6086. 19 indexed citations
11.
Gafos, Mitzy, David Dolling, Monica Desai, et al.. (2014). Sexual Behaviour Profile of Gay and Other Men Who Have Sex with Men Enrolled in the PROUD Pre-exposure Prophylaxis Open-label Pilot Study in England. AIDS Research and Human Retroviruses. 30(S1). A22–A22.
12.
Jackson, Akil, Laura Else, Pedro M. M. Mesquita, et al.. (2014). A Compartmental Pharmacokinetic Evaluation of Long-Acting Rilpivirine in HIV-Negative Volunteers for Pre-Exposure Prophylaxis. Clinical Pharmacology & Therapeutics. 96(3). 314–323. 89 indexed citations
13.
Jackson, Akil, Victoria Watson, David Back, et al.. (2011). Plasma and Intracellular Pharmacokinetics of Darunavir/Ritonavir Once Daily and Raltegravir Once and Twice Daily in HIV-Infected Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(5). 450–457. 27 indexed citations
14.
Cheeseman, Hannah M., Jakub Kopycinski, Lorna Clark, et al.. (2011). Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials. Journal of Immunological Methods. 370(1-2). 43–54. 9 indexed citations
15.
Lyman, Edward, Chris Higgs, Byungchan Kim, et al.. (2009). A Role for a Specific Cholesterol Interaction in Stabilizing the Apo Configuration of the Human A 2A Adenosine Receptor. Structure. 17(12). 1660–1668. 105 indexed citations
16.
17.
Moyle, Graeme, et al.. (2002). Interaction between saquinavir soft‐gel and rifabutin in patients infected with HIV. British Journal of Clinical Pharmacology. 54(2). 178–182. 12 indexed citations
18.
Ives, Natalie, et al.. (2001). Does an HIV clinical trial information booklet improve patient knowledge and understanding of HIV clinical trials?. HIV Medicine. 2(4). 241–249. 15 indexed citations
19.
Higgs, Chris, et al.. (2000). Domestic Water Use Study. 141. 55 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joan Albert Arnáiz Breakdown of academic impact, for papers by Maria José Míguez‐Burbano Breakdown of academic impact, for papers by Birgit Kvinesdal Breakdown of academic impact, for papers by Haijiang Lin Breakdown of academic impact, for papers by Daniel Pearce Breakdown of academic impact, for papers by Isabelle Kousignian Breakdown of academic impact, for papers by Anthony T. Podany Breakdown of academic impact, for papers by Miranda Murray Breakdown of academic impact, for papers by Carlin Rafie Breakdown of academic impact, for papers by William P. Howlett
Rankless by CCL
2026